Lixin Han

414 total citations
20 papers, 301 citations indexed

About

Lixin Han is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lixin Han has authored 20 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Lixin Han's work include Selenium in Biological Systems (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lixin Han is often cited by papers focused on Selenium in Biological Systems (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lixin Han collaborates with scholars based in China, United States and United Kingdom. Lixin Han's co-authors include Rongqiang Zhang, Xiaoli Yang, Fengying Li, Yonghong Ma, Heather Gordish‐Dressman, Erik Henricson, Geoffrey I. Shapiro, Linda Lowes, Jerry R. Mendell and Helen Eliopoulos and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Lixin Han

19 papers receiving 295 citations

Peers

Lixin Han
Comparison fields: 5 of 73
  • Molecular Biology 157
  • Oncology 49
  • Genetics 45
  • Pulmonary and Respiratory Medicine 43
  • Complementary and alternative medicine 42
Replace Yin Huang with:
Yin Huang China
Asako Takeuchi Japan
Faith Kwa Australia
JM Li China
Wilhelm Geilen Germany
Maya Suzuki Japan
Li B China
Chunsong Hu China
Junni Wang China
Xianghou Xia China
Yin Huang China View profile →
Citations per field, relative to Lixin Han
Lixin Han · 1×
Citations per year, relative to Lixin Han
Lixin Han · 1×

Countries citing papers authored by Lixin Han

Since Specialization
Citations

This map shows the geographic impact of Lixin Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Han more than expected).

Fields of papers citing papers by Lixin Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Han. The network helps show where Lixin Han may publish in the future.

Co-authorship network of co-authors of Lixin Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Han. A scholar is included among the top collaborators of Lixin Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Han. Lixin Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 1
4 13
5 1
6 2
7 1
8 67
9 3
10 25
11 13
12 12
13 52
14 1
15 5
16 2
17 97
18 1
19 2
20 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026